Revenue and net profit for Q2 FY26 were stable year-over-year, with a slight dip in operating profit and cash flow. Specialty chemicals remained the sole business segment, and the company maintained strong compliance and capital discipline.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.